Antidepressant combination versus antidepressants plus second-generation antipsychotic augmentation in treatment-resistant unipolar depression-Reference-Cited by-同舟云学术

Antidepressant combination versus antidepressants plus second-generation antipsychotic augmentation in treatment-resistant unipolar depression

Published:2018-01 Issue:1 Volume:33 Page:34-43
ISSN:0268-1315
Container-title:International Clinical Psychopharmacology
language:en
Short-container-title:International Clinical Psychopharmacology

Author:

Gobbi Gabriella,Ghabrash Maykel F.,Nuñez Nicolas,Tabaka John,Di Sante Jessica,Saint-Laurent Marie,Vida Stephen,Kolivakis Theodore,Low Nancy,Cervantes Pablo,Booij Linda,Comai Stefano

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference64 articles.

1. Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder

2. A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder

3. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders

4. The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder

5. Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2);Journal of Psychiatric Research;2024-08

2. Recent Advances in the Treatment of Treatment-Resistant Depression: A Narrative Review of Literature Published from 2018 to 2023;Current Psychiatry Reports;2024-02-22

3. Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms;BMC Medicine;2024-01-25

4. Treatment-Resistant Depression in Real-World Clinical Practice: A Systematic Literature Review of Data from 2012 to 2022;Advances in Therapy;2023-10-26

5. Concordance of the treatment patterns for major depressive disorders between the Canadian Network for Mood and Anxiety Treatments (CANMAT) algorithm and real-world practice in China;Frontiers in Pharmacology;2022-08-31